|
Consumer Group Seeks FDA Ban on Avandia
Public Citizen cites liver failure deaths, other risks of adverse events for diabetes drug
Many Trial Reports on FDA-Approved Drugs Go Unpublished
Selective reporting may color record of comparisons to other meds, study says
Group Works to Streamline Cancer Therapy Approvals
6-point flow chart seeks to clarify most productive research lines for FDA consideration
New Lymphoma Drug Shows Promise
Eleven of 38 non-Hodgkin patients respond to blinatumomab, study finds
|
